vs

Side-by-side financial comparison of MEDIFAST INC (MED) and Midland States Bancorp, Inc. (MSBI). Click either name above to swap in a different company.

Midland States Bancorp, Inc. is the larger business by last-quarter revenue ($79.5M vs $75.1M, roughly 1.1× MEDIFAST INC). Over the past eight quarters, Midland States Bancorp, Inc.'s revenue compounded faster (-6.4% CAGR vs -34.4%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

Rainier Bancorporation was the Seattle-based parent corporation of Rainier National Bank, a Washington state bank with branches throughout the state. Rainier traced its roots back to the National Bank of Commerce, which was founded by Richard Holyoke in 1889. The name Rainier National Bank was adopted in 1974. Rainier Bancorp expanded into Alaska with the purchase of Anchorage's People's Bank & Trust in 1983 and into Oregon with the purchase of Gresham's Mount Hood Security Bank in 1986, expa...

MED vs MSBI — Head-to-Head

Bigger by revenue
MSBI
MSBI
1.1× larger
MSBI
$79.5M
$75.1M
MED
Faster 2-yr revenue CAGR
MSBI
MSBI
Annualised
MSBI
-6.4%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
MED
MED
MSBI
MSBI
Revenue
$75.1M
$79.5M
Net Profit
$18.5M
Gross Margin
69.4%
Operating Margin
-10.4%
Net Margin
23.2%
Revenue YoY
-36.9%
Net Profit YoY
739.3%
EPS (diluted)
$-1.64
$0.74

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
MSBI
MSBI
Q1 26
$79.5M
Q4 25
$75.1M
$85.6M
Q3 25
$89.4M
$81.1M
Q2 25
$105.6M
$82.2M
Q1 25
$115.7M
$76.1M
Q4 24
$119.0M
$93.9M
Q3 24
$140.2M
$92.7M
Q2 24
$168.6M
$90.9M
Net Profit
MED
MED
MSBI
MSBI
Q1 26
$18.5M
Q4 25
$-2.9M
Q3 25
$-2.3M
$7.6M
Q2 25
$2.5M
$12.0M
Q1 25
$-772.0K
$-141.0M
Q4 24
$-30.8M
Q3 24
$1.1M
$20.4M
Q2 24
$-8.2M
$25.7M
Gross Margin
MED
MED
MSBI
MSBI
Q1 26
Q4 25
69.4%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
Q3 24
75.4%
Q2 24
73.2%
Operating Margin
MED
MED
MSBI
MSBI
Q1 26
Q4 25
-10.4%
-5.5%
Q3 25
-4.6%
13.9%
Q2 25
-1.0%
18.1%
Q1 25
-1.1%
-181.2%
Q4 24
0.6%
-66.5%
Q3 24
1.5%
26.9%
Q2 24
-4.7%
35.0%
Net Margin
MED
MED
MSBI
MSBI
Q1 26
23.2%
Q4 25
-4.9%
Q3 25
-2.5%
9.3%
Q2 25
2.3%
14.6%
Q1 25
-0.7%
-185.4%
Q4 24
-52.5%
Q3 24
0.8%
22.1%
Q2 24
-4.8%
28.3%
EPS (diluted)
MED
MED
MSBI
MSBI
Q1 26
$0.74
Q4 25
$-1.64
$-0.22
Q3 25
$-0.21
$0.24
Q2 25
$0.22
$0.44
Q1 25
$-0.07
$-6.58
Q4 24
$0.08
$-1.49
Q3 24
$0.10
$0.83
Q2 24
$-0.75
$1.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
MSBI
MSBI
Cash + ST InvestmentsLiquidity on hand
$167.3M
$89.4M
Total DebtLower is stronger
$33.2M
Stockholders' EquityBook value
$198.9M
$569.5M
Total Assets
$248.0M
$6.5B
Debt / EquityLower = less leverage
0.06×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
MSBI
MSBI
Q1 26
$89.4M
Q4 25
$167.3M
$127.8M
Q3 25
$173.5M
$166.1M
Q2 25
$162.7M
$176.6M
Q1 25
$164.6M
$102.0M
Q4 24
$162.3M
$114.8M
Q3 24
$170.0M
$121.9M
Q2 24
$163.5M
$124.6M
Total Debt
MED
MED
MSBI
MSBI
Q1 26
$33.2M
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
MED
MED
MSBI
MSBI
Q1 26
$569.5M
Q4 25
$198.9M
$565.5M
Q3 25
$214.7M
$584.0M
Q2 25
$216.0M
$573.7M
Q1 25
$211.0M
$571.4M
Q4 24
$210.1M
$710.8M
Q3 24
$207.3M
$771.2M
Q2 24
$205.3M
$736.8M
Total Assets
MED
MED
MSBI
MSBI
Q1 26
$6.5B
Q4 25
$248.0M
$6.5B
Q3 25
$268.2M
$6.9B
Q2 25
$269.3M
$7.1B
Q1 25
$280.0M
$7.3B
Q4 24
$284.2M
$7.5B
Q3 24
$291.2M
$7.7B
Q2 24
$293.5M
$7.7B
Debt / Equity
MED
MED
MSBI
MSBI
Q1 26
0.06×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
MSBI
MSBI
Operating Cash FlowLast quarter
$-5.3M
Free Cash FlowOCF − Capex
$-6.6M
FCF MarginFCF / Revenue
-8.8%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
MSBI
MSBI
Q1 26
Q4 25
$-5.3M
$125.7M
Q3 25
$12.1M
$80.0M
Q2 25
$-3.4M
$28.1M
Q1 25
$3.4M
$24.7M
Q4 24
$-4.9M
$176.5M
Q3 24
$9.1M
$46.5M
Q2 24
$13.1M
$31.4M
Free Cash Flow
MED
MED
MSBI
MSBI
Q1 26
Q4 25
$-6.6M
$120.3M
Q3 25
$10.8M
$78.6M
Q2 25
$-4.8M
$26.7M
Q1 25
$1.9M
$22.9M
Q4 24
$-7.2M
$169.6M
Q3 24
$7.7M
$44.4M
Q2 24
$11.1M
$29.9M
FCF Margin
MED
MED
MSBI
MSBI
Q1 26
Q4 25
-8.8%
140.6%
Q3 25
12.0%
96.9%
Q2 25
-4.5%
32.4%
Q1 25
1.6%
30.1%
Q4 24
-6.1%
180.6%
Q3 24
5.5%
47.9%
Q2 24
6.6%
32.9%
Capex Intensity
MED
MED
MSBI
MSBI
Q1 26
Q4 25
1.8%
6.2%
Q3 25
1.5%
1.7%
Q2 25
1.3%
1.7%
Q1 25
1.3%
2.4%
Q4 24
1.9%
7.3%
Q3 24
1.0%
2.3%
Q2 24
1.1%
1.7%
Cash Conversion
MED
MED
MSBI
MSBI
Q1 26
Q4 25
Q3 25
10.58×
Q2 25
-1.36×
2.33×
Q1 25
Q4 24
Q3 24
8.04×
2.28×
Q2 24
1.22×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MED
MED

Segment breakdown not available.

MSBI
MSBI

Net Interest Income$57.4M72%
Noninterest Income$22.1M28%

Related Comparisons